LiMM Therapeutics

About:

LiMM Therapeutics is a biopharmaceutical company that harnesses the molecular cross-talk between neuronal and innate lymphoid cells.

Website: https://www.limmtx.com/

Top Investors: European Innovation Council, Seventure Partners, Portugal Ventures, PME Investimentos, 200M

Description:

LiMM Therapeutics operates as a biopharmaceutical company that harnesses the molecular cross-talk between neuronal and innate lymphoid cells. It develops products designed to preserve health and treat inflammatory, infectious, and metabolic diseases. The company is dedicated to bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients.

Total Funding Amount:

7M EUR

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2017-01-01

Founders:

David Braga Malta, José Henrique Veiga-Fernandes

Number of Employees:

11-50

Last Funding Date:

2021-10-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai